Outcome MeasureOther

BES

Binge Eating Scale

1 Paper in Blossom

Outcome Data Across Studies

Reported results for BES across 1 study with quantitative data.

Outcome data across 1 study arm–timepoint observations
SD
An open-label pilot study of psilocybin-assisted therapy for binge eating disorder
2026Exploratory
Open Label Oral Psilocybin(experimental)0527.4——

Papers Using BES

Open Accessindividual

An open-label pilot study of psilocybin-assisted therapy for binge eating disorder

This open-label pilot study (n=5) tested a single 25 mg dose of psilocybin with Acceptance and Commitment Therapy-based psychotherapy in adults with binge eating disorder and found the treatment was feasible and well tolerated, with no serious adverse events. Participants reported fewer binge eating episodes, along with improvements in depression, anxiety and psychological flexibility over 14 weeks.

Published
Journal
Journal of Eating Disorders
Authors
Dallery, J., Miller, J. L., Boissoneault, J., Harvey, L., Ives, L., Knerr, A., Blaes, S., Ransom, M. N., Munson, M., Gilligan, J. P., Silverman, M. H., Guzzo, P. R., Loeser, B.

Quick Facts

Full Name
Binge Eating Scale
Domain
Other
Papers Indexed
1
Score Range
0–46
Interpretation
Lower = better
Unit
points
All Measures